Objectives The aim of this study was to explore the views and experiences of a group of
Spanish women suffering from chronic migraine (CM). Setting Headache clinic at a university …

With molecular treatments coming into reach for spinocerebellar ataxia type 3 ( SCA 3),
easily accessible, cross‐species validated biomarkers for human and preclinical trials are …

Background Given that new therapeutic options for spinocerebellar ataxias are on the
horizon, there is a need for markers that reflect disease‐related alterations, in particular, in the …

… ataxia type 3 - Garcia‐Moreno - 2022 - European Journal of Neurology - Wiley Online
Library … Hector Garcia-Moreno and Mercedes Prudencio contributed equally to the paper. …

Quantifying the volume of the cerebellum and its lobes is of profound interest in various
neurodegenerative and acquired diseases. Especially for the most common spinocerebellar …

Topoisomerase 3α (TOP3A) is an enzyme that removes torsional strain and interlinks
between DNA molecules. TOP3A localises to both the nucleus and mitochondria, with the two …

Spinocerebellar ataxia type 3 (SCA3), caused by a CAG repeat expansion in the ataxin-3 gene
(ATXN3), is characterized by neuronal polyglutamine (polyQ) ATXN3 protein aggregates. …

Transcriptional dysregulation has been described in spinocerebellar ataxia type 3/Machado-Joseph
disease (SCA3/MJD), an autosomal dominant ataxia caused by a polyglutamine …

Objective. Atypical odontalgia (AO), a subform of persistent idiopathic facial pain, is defined
as a continuous toothache in which a thorough examination reveals no dental pathology. AO …

Background Spinocerebellar ataxia type 3 is a rare neurodegenerative disease caused by a
CAG repeat expansion in the ataxin‐3 gene. Although no curative therapy is yet available, …